首頁 > 市場調查報告書 > 製藥

疫苗感染疾病

市場調查報告書

商品編碼

1541063

2024-2032 年腦膜炎雙球菌疫苗市場報告（按疫苗類型、成分、疫苗血清型、配銷通路、最終用戶和地區分類）

Meningococcal Vaccines Market Report by Vaccine Type, Composition, Vaccine Serotype, Distribution Channel, End User, and Region 2024-2032

出版日期: 2024年08月10日 | 出版商:

IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球腦膜炎雙球菌疫苗市場規模達36億美元。

腦膜炎雙球菌疫苗是指用於預防腦膜炎的生物物質，腦膜炎是脊髓和大腦周圍膜的傳染性感染。腦膜炎雙球菌疫苗的三種主要類型包括結合疫苗、多醣體疫苗和莢膜下腦膜炎雙球菌疫苗。給嬰兒、兒童和成人注射疫苗，使他們對侵襲性疾病產生免疫，並針對腦膜炎雙球菌 A、B、C、W-135 和 Y。防止日後感染。

全球幼兒和青少年中腦膜炎球菌疾病的盛行率不斷上升，是推動市場成長的關鍵因素之一。此外，群眾健康意識的提高和常規免疫接種的採用也為市場成長提供了動力。腦膜炎雙球菌疫苗有助於預防這種疾病並最大限度地減少長期影響，例如暫時或永久性耳聾、視力和運動技能喪失、癲癇發作和神經損傷。為此，已開發經濟體和新興經濟體政府都在啟動廣泛的公共衛生計劃，同時強調對遊客和軍人等特殊風險群體進行免疫接種，以控制感染風險。此外，各種產品創新，例如開發不需要重構的即用液體配方，也有助於市場成長。其他因素，包括廣泛的研發（R＆D）活動以及醫療保健基礎設施的改善，預計將進一步推動市場發展。

本報告回答的關鍵問題：

迄今為止，全球腦膜炎雙球菌疫苗市場表現如何，未來幾年將如何表現？
COVID-19 對全球腦膜炎雙球菌疫苗市場有何影響？
主要區域市場有哪些？
根據疫苗類型，市場的詳細情形如何？
根據構成，市場的細分是怎樣的？
根據疫苗血清型的市場分類是怎樣的？
基於配銷通路的市場區隔是什麼？
基於最終用戶的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球腦膜炎雙球菌疫苗市場的結構如何？
產業競爭程度如何？

北美洲
- 美國
- 加拿大
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 其他
歐洲
- 德國
- 法國
- 英國
- 義大利
- 西班牙
- 俄羅斯
- 其他
拉丁美洲
- 巴西
- 墨西哥
- 其他
中東和非洲
- 市場趨勢
- 市場細分：按國家/地區
- 市場預測

第 12 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 15 章：價格分析

第16章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- GlaxoSmithKline Plc
- Hualan Biological Engineering Inc.
- Incepta Pharmaceuticals Limited
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Ltd.
- Walvax Biotechnology Co. Ltd.

簡介目錄圖表

Product Code: SR112024A2730

The global meningococcal vaccines market size reached US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032.

Meningococcal vaccine refers to a biological substance administered for the prevention of meningitis, which is a contagious infection of the membranes surrounding the spinal cord and the brain. The three main kinds of meningococcal vaccines include conjugate, polysaccharide and subcapsular meningococcal vaccines. They are administered to infants, children and adults to immunize them against the invasive disease and target meningococcal bacteria A, B, C, W-135 and Y. Once the vaccine is administered, antibodies are formed to fight the bacteria and create an immune response to prevent the infection in the future.

The increasing prevalence of the meningococcal disease among young children and adolescents across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising health consciousness among the masses and the adoption of routine immunization are providing a thrust to the market growth. Meningococcal vaccine aids in preventing the disease and minimizing the long-term effects, such as temporary or permanent deafness, loss of vision and motor skills, seizure and neurological damage. In line with this, governments of both developed and emerging economies are launching extensive public health programs while emphasizing on the immunization of special risk groups, such as tourists and military personnel, to contain the risks of infections. Additionally, various product innovations, such as the development of ready-to-use liquid formulations that do not require reconstitution, are also contributing to the market growth. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global meningococcal vaccines market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on vaccine type, composition, vaccine serotype, distribution channel and end user.

Breakup by Vaccine Type:

Conjugate

Polysaccharide

Subcapsular

Breakup by Composition:

Mono Vaccines

Combination Vaccines

Breakup by Vaccine Serotype:

MenACWY

MenB & Manic

MenC

MenA

MenAC

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Institutional Sales

Others

Breakup by End User:

Pediatric

Adult

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.

Key Questions Answered in This Report:

How has the global meningococcal vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global meningococcal vaccines market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the composition?
What is the breakup of the market based on the vaccine serotype?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global meningococcal vaccines market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Meningococcal Vaccines Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Vaccine Type

6.1 Conjugate
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Polysaccharide
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Subcapsular
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Composition

7.1 Mono Vaccines
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Combination Vaccines
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Vaccine Serotype

8.1 MenACWY
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 MenB & Manic
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 MenC
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 MenA
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 MenAC
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Institutional Sales
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by End User

10.1 Pediatric
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Adult
- 10.2.1 Market Trends
- 10.2.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 GlaxoSmithKline Plc
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
  - 16.3.1.4 SWOT Analysis
- 16.3.2 Hualan Biological Engineering Inc.
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
  - 16.3.2.3 Financials
- 16.3.3 Incepta Pharmaceuticals Limited
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
- 16.3.4 Novartis AG
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
  - 16.3.4.3 Financials
  - 16.3.4.4 SWOT Analysis
- 16.3.5 Pfizer Inc.
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
  - 16.3.5.3 Financials
  - 16.3.5.4 SWOT Analysis
- 16.3.6 Sanofi S.A.
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
  - 16.3.6.3 Financials
  - 16.3.6.4 SWOT Analysis
- 16.3.7 Serum Institute of India Ltd.
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
- 16.3.8 Walvax Biotechnology Co. Ltd.
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Meningococcal Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Meningococcal Vaccines Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Meningococcal Vaccines Market: Breakup by Vaccine Type (in %), 2023
Figure 4: Global: Meningococcal Vaccines Market: Breakup by Composition (in %), 2023
Figure 5: Global: Meningococcal Vaccines Market: Breakup by Vaccine Serotype (in %), 2023
Figure 6: Global: Meningococcal Vaccines Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Meningococcal Vaccines Market: Breakup by End User (in %), 2023
Figure 8: Global: Meningococcal Vaccines Market: Breakup by Region (in %), 2023
Figure 9: Global: Meningococcal Vaccines Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: Global: Meningococcal Vaccines (Conjugate) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Meningococcal Vaccines (Conjugate) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Meningococcal Vaccines (Polysaccharide) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Meningococcal Vaccines (Polysaccharide) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Meningococcal Vaccines (Subcapsular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Meningococcal Vaccines (Subcapsular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Meningococcal Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Meningococcal Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Meningococcal Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Meningococcal Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Meningococcal Vaccines (MenACWY) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Meningococcal Vaccines (MenACWY) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Meningococcal Vaccines (MenB & Manic) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Meningococcal Vaccines (MenB & Manic) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Meningococcal Vaccines (MenC) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Meningococcal Vaccines (MenC) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Meningococcal Vaccines (MenA) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Meningococcal Vaccines (MenA) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Meningococcal Vaccines (MenAC) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Meningococcal Vaccines (MenAC) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Meningococcal Vaccines (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Meningococcal Vaccines (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Meningococcal Vaccines (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Meningococcal Vaccines (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Meningococcal Vaccines (Institutional Sales) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Meningococcal Vaccines (Institutional Sales) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Global: Meningococcal Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Global: Meningococcal Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Global: Meningococcal Vaccines (Pediatric) Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Global: Meningococcal Vaccines (Pediatric) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Global: Meningococcal Vaccines (Adult) Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Global: Meningococcal Vaccines (Adult) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: North America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: North America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: United States: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: United States: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Canada: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Canada: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Asia Pacific: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Asia Pacific: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: China: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: China: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Japan: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Japan: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: India: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: India: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: South Korea: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: South Korea: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Australia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Australia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Indonesia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Indonesia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Europe: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Europe: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Germany: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Germany: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: France: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: France: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: United Kingdom: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: United Kingdom: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Italy: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Italy: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Spain: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Spain: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Russia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Russia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Latin America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Latin America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Brazil: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Brazil: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Mexico: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 87: Mexico: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 88: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 89: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 90: Middle East and Africa: Meningococcal Vaccines Market: Sales Value (in Million US$), 2018 & 2023
Figure 91: Middle East and Africa: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 92: Global: Meningococcal Vaccines Industry: SWOT Analysis
Figure 93: Global: Meningococcal Vaccines Industry: Value Chain Analysis
Figure 94: Global: Meningococcal Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Meningococcal Vaccines Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2024-2032
Table 3: Global: Meningococcal Vaccines Market Forecast: Breakup by Composition (in Million US$), 2024-2032
Table 4: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Serotype (in Million US$), 2024-2032
Table 5: Global: Meningococcal Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Meningococcal Vaccines Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 7: Global: Meningococcal Vaccines Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 8: Global: Meningococcal Vaccines Market: Competitive Structure
Table 9: Global: Meningococcal Vaccines Market: Key Players

02-2729-4219

+886-2-2729-4219